Table 4.
Patient AEs | Volume value | P-value | |
---|---|---|---|
44 fractions (arm 1) | |||
V50 ≤ 15% | V50 > 15% | ||
With bowel AE, n | 1 | 3 | |
Without bowel AE, n | 10 | 11 | |
Rate bowel AEs, % | 9.1 | 21.4 | .60 |
V70 ≤ 8% | V70 > 8% | ||
With bowel AE, n | 1 | 3 | |
Without bowel AE, n | 10 | 11 | |
Rate bowel AEs, % | 9.1 | 21.4 | .60 |
V80 ≤ 4 cc | V80 > 4 cc | ||
With urinary AE, n | 2 | 8 | |
Without urinary AE, n | 10 | 5 | |
Rate urinary AEs, % | 16.7 | 61.5 | .04a |
5 fractions (arm 2) | |||
V24 ≤ 14% | V24 > 14% | ||
With bowel AE, n | 5 | 4 | |
Without bowel AE, n | 19 | 17 | |
Rate bowel AEs, % | 20.8 | 19.0 | > .99 |
V33.6 ≤ 7% | V33.6 > 7% | ||
With bowel AE, n | 4 | 5 | |
Without bowel AE, n | 18 | 18 | |
Rate bowel AEs, % | 18.2 | 21.7 | > .99 |
V39 ≤ 0.349 cc | V39 > 0.349 cc | ||
With urinary AE, n | 10 | 6 | |
Without urinary AE, n | 26 | 3 | |
Rate urinary AEs, % | 27.8 | 66.7 | .05a |
AE, adverse event.
Statistically significant.